We provide a summary of the biomarkers and assays identified as well as a more in-depth exploratory evaluation of the longitudinal change in levels of C-reactive protein (CRP), interferon gamma-induced protein 10 (IP-10), interleukin-6 (IL-6), and tumor necrosis factor alpha (TNF-α) during anti-TB treatment. Here, CRP is linked to tuberculosis.